About LEE'S PHARM Company

The company is a research-led and market-oriented biomedical company that has been operating in the Chinese pharmaceutical industry for over 25 years. The Group has an international perspective and is closely integrated with the solid infrastructure established in mainland China for drug development, clinical development, regulation, manufacturing, sales and marketing. The Group has established extensive cooperative relationships with more than 20 international companies, and is currently promoting more than 25 kinds of patented, generic and imported pharmaceutical products in mainland China, Hong Kong, Macau and Taiwan. The Group is committed to various important disease fields such as cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. There are more than 40 types of products at different stages of development, from in-house research and development as well as development, commercialization and production rights introduced from American, European and Japanese companies. The Group carries out sales and distribution activities in Hong Kong, Macau, Taiwan and mainland China through direct sales and pipeline sales networks covering most provinces and cities in mainland China through its Hong Kong and Taiwan offices and branches in Chongqing, Guangzhou, Shanghai and Beijing, to promote products developed and imitation domestically and products imported from overseas. The Group has just set up an office in Thailand and intends to conduct sales and distribution activities in the Thai market in the near future. Zhaoke Hefei currently operates the Group's production plant in Hefei, Anhui Province, China. The plant has four GMP-compliant factories, which are responsible for the production of gels, freeze-dried powder injections for injection, small-volume injections and eye gels. Zhaoke Guangzhou is currently operating a pharmaceutical factory in Nansha District, Guangzhou, China (including the development and production of a complete solid formulation production line for tablets and capsules). The Group's mission is to become a successful biomedical group in Asia, providing innovative products to fight disease, improve health and enhance quality of life.